Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dade and Cardiovascular Diagnostics form distribution agreement

This article was originally published in Clinica

Executive Summary

Dade International and Cardiovascular Diagnostics have entered into an exclusive, five-year development and distribution agreement for point-of-care haemostasis testing. Under the agreement, Dade will distribute Cardiovascular's Thrombolytic Assessment System (TAS) under a joint label to hospital and non-hospital laboratories. TAS technology includes an analyser and test cards (see Clinica No 693, p 17). The companies estimate that the agreement will result in sales of more than $100 million over the next five years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel